Immunogenicity and Safety of DCs in Breast Cancer
NCT03450044
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Female
Interventions
BIOLOGICAL:
Dendritic cells
Sponsor
Fundación Salud de los Andes
Collaborators
[object Object]
[object Object]